Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
Author:
Funder
Novo Nordisk
Novartis
Shionogi
Gilead Sciences
Merck
AbbVie
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference27 articles.
1. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents;Calvaruso;Gastroenterology,2018
2. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: a retrospective study;Colussi;World J Gastroenterol,2019
3. An in-depth analysis of patient-reported outcomes in patients with chronic hepatitis C treated with different anti-viral regimens;Younossi;Am J Gastroenterol,2016
4. Sofosbuvir and velpatasvir combination improves patient-reported outcomes for patients with HCV infection, without or with compensated or decompensated cirrhosis;Younossi;Clin Gastroenterol Hepatol,2017
5. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens;Younossi;Hepatology,2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Systematic Literature Review and Meta-Analysis of Primary Evidence Reporting Health-State Preference Values in Chronic Hepatitis B, C, and D;Value in Health;2024-06
2. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years;Gastroenterología y Hepatología;2024-05
3. Assessment of fatigue and its impact in chronic liver disease;Journal of Hepatology;2024-04
4. Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China;BMC Infectious Diseases;2024-01-10
5. Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals;Journal of Clinical Medicine;2023-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3